Schiffelers R M, Molema G, ten-Hagen T L, et al. Ligand-targeted liposomes directed against pathological vasculature[J]. J Liposome Res, 2002, 12(1/2): 129-135. [2]Xiong X B, Huang Y, Lu W L, et al. Enhanced intracellular uptake of sterically stabilized liposomal Doxorubicin ？in vitro？ resulting in improved antitumor activity ？in vivo [J]. Pharm Res, 2005, 22(6): 933-939. [3]Qin Y, Chen H, Yuan W, et al. Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery[J]. Int J Pharm, 2011, 419(1/2): 85-95. [4]Khalil I A, Kogure K, Futaki S, et al. Octaarginine-modified liposomes: enhanced cellular uptake and controlled intracellular trafficking[J]. Int J Pharm, 2008, 354(1/2): 39-48. [5]Al-Soraj M, He L, Peynshaert K, et al. siRNA and pharmacological inhibition of endocytic pathways to characterize the differential role of macropinocytosis and the actin cytoskeleton on cellular uptake of dextran and cationic cell penetrating peptides octaarginine (R8) and HIV-Tat[J]. J Control Release, 2012, 161(1): 132-141. [6]Oba M, Fukushima S, Kanayama N, et al. Cyclic RGD peptide-conjugated polyplex micelles as a targetable gene delivery system directed to cells possessing alphavbeta3 and alphavbeta5 integrins[J]. Bioconjug Chem, 2007,18(5): 1415-1423. [7]Zhan C, Gu B, Xie C, et al. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect[J]. J Control Release, 2010, 143(1): 136-142. [8]Ying X, Wen H, Lu W L, et al. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals[J]. J Control Release, 2010, 141(2): 183-192. [9]Jiang X, Xin H, Gu J, et al. Solid tumor penetration by integrin-mediated pegylatedoly(trimethylene carbonate) nanoparticles loaded with paclitaxel[J]. Biomaterials, 2013,34(6): 1739-1746. [10]Zhang Q, Tang J, Fu L, et al A pH-responsive a-helical cell penetrating peptide-mediated liposomal delivery system[J]. Biomaterials, 2013, 34(32): 7980-7993. [11]Zhang L, Zhang L. Lipid-polymer hybrid nanoparticles: synthesis, characterization and applications[J]. Nano LIFE, 2010,1(1/2): 163-173. [12]Maeda H, Wu J, Sawa T, et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review[J]. J Control Release, 2000, 65(1/2): 271-284. [13]Li J, Feng L, Fan L, et al. Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides[J]. Biomaterials, 2011, 32(21): 4943-4950.
